Paeonia genus: a systematic review of active ingredients, pharmacological effects and mechanisms, and clinical applications for the treatment of cancer
Xinrui Zhou, Aikebaier Alimu, Jiarui Zhao, Xinyi Xu, Xiaowen Li, He Lin, Zhe Lin
{"title":"Paeonia genus: a systematic review of active ingredients, pharmacological effects and mechanisms, and clinical applications for the treatment of cancer","authors":"Xinrui Zhou, Aikebaier Alimu, Jiarui Zhao, Xinyi Xu, Xiaowen Li, He Lin, Zhe Lin","doi":"10.1007/s12272-024-01512-2","DOIUrl":null,"url":null,"abstract":"<div><p>The main active constituents of plants of the Paeonia genus are known to have antitumor activity. Hundreds of compounds with a wide range of pharmacological activities, including monoterpene glycosides, flavonoids, tannins, stilbenes, triterpenoids, steroids, and phenolic compounds have been isolated. Among them, monoterpenes and their glycosides, flavonoids, phenolic acids, and other constituents have been shown to have good therapeutic effects on various cancers, with the main mechanisms including the induction of apoptosis; the inhibition of tumor cell proliferation, migration, and invasion; and the modulation of immunity. In this study, many citations related to the traditional uses, phytochemical constituents, antitumor effects, and clinical applications of the Paeonia genus were retrieved from popular and widely used databases such as Web of Science, Science Direct, Google Scholar, and PubMed using different search strings. A systematic review of the antitumor constituents of the Paeonia genus and their therapeutic effects on various cancers was conducted and the mechanisms of action and pathways of these phytochemicals were summarised to provide a further basis for antitumor research.</p></div>","PeriodicalId":8287,"journal":{"name":"Archives of Pharmacal Research","volume":"47 8-9","pages":"677 - 695"},"PeriodicalIF":6.9000,"publicationDate":"2024-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Pharmacal Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12272-024-01512-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
The main active constituents of plants of the Paeonia genus are known to have antitumor activity. Hundreds of compounds with a wide range of pharmacological activities, including monoterpene glycosides, flavonoids, tannins, stilbenes, triterpenoids, steroids, and phenolic compounds have been isolated. Among them, monoterpenes and their glycosides, flavonoids, phenolic acids, and other constituents have been shown to have good therapeutic effects on various cancers, with the main mechanisms including the induction of apoptosis; the inhibition of tumor cell proliferation, migration, and invasion; and the modulation of immunity. In this study, many citations related to the traditional uses, phytochemical constituents, antitumor effects, and clinical applications of the Paeonia genus were retrieved from popular and widely used databases such as Web of Science, Science Direct, Google Scholar, and PubMed using different search strings. A systematic review of the antitumor constituents of the Paeonia genus and their therapeutic effects on various cancers was conducted and the mechanisms of action and pathways of these phytochemicals were summarised to provide a further basis for antitumor research.
众所周知,芍药属植物的主要活性成分具有抗肿瘤活性。目前已分离出数百种具有广泛药理活性的化合物,包括单萜苷类、黄酮类、单宁类、二苯乙烯类、三萜类、甾体类和酚类化合物。其中,单萜及其苷类、黄酮类、酚酸类和其他成分已被证明对各种癌症有良好的治疗效果,主要机制包括诱导细胞凋亡;抑制肿瘤细胞增殖、迁移和侵袭;以及调节免疫。本研究使用不同的搜索字符串,从流行且广泛使用的数据库(如 Web of Science、Science Direct、Google Scholar 和 PubMed)中检索了许多与芍药属植物的传统用途、植物化学成分、抗肿瘤作用和临床应用相关的引文。对芍药属植物的抗肿瘤成分及其对各种癌症的治疗效果进行了系统综述,并总结了这些植物化学物质的作用机制和途径,为抗肿瘤研究提供了进一步的依据。
期刊介绍:
Archives of Pharmacal Research is the official journal of the Pharmaceutical Society of Korea and has been published since 1976. Archives of Pharmacal Research is an interdisciplinary journal devoted to the publication of original scientific research papers and reviews in the fields of drug discovery, drug development, and drug actions with a view to providing fundamental and novel information on drugs and drug candidates.